TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Whisenant, Jennifer G., Trama, Annalisa, Torri, Valter, De Toma, Alessandro, Viscardi, Giuseppe, Cortellini, Alessio, Michielin, Olivier, Barlesi, Fabrice, Dingemans, Anne-Marie C., Van Meerbeeck, Jan, Pancaldi, Vera, Soo, Ross A., Leighl, Natasha B., Peters, Solange, Wakelee, Heather, Garassino, Marina Chiara, Horn, Leora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229923/
https://www.ncbi.nlm.nih.gov/pubmed/32425702
http://dx.doi.org/10.1016/j.ccell.2020.05.008
Descripción
Sumario:Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.

Ejemplares similares